CS from P. berghei str. ANKA
General Information
Protegen ID
633
Sequence Strain (Species/Organism)
Plasmodium berghei ANKA
VO ID
VO_0011217
Taxonomy ID
5823
Molecule Role
Protective antigen
Molecule Role Annotation
Researchers produced a prototypic malaria vaccine based on a highly versatile self-assembling polypeptide nanoparticle (SAPN) platform that can repetitively display antigenic epitopes. Researchers used this platform to display a tandem repeat of the B cell immunodominant repeat epitope (DPPPPNPN)(2)D of the malaria parasite Plasmodium berghei circumsporozoite (CS) protein. Administered in saline, without the need for a heterologous adjuvant, the SAPN construct P4c-Mal conferred a long-lived, protective immune response to mice with a broad range of genetically distinct immune backgrounds including the H-2(b), H-2(d), and H-2(k) alleles. Mice were protected against an initial challenge of parasites up to 6 mo after the last immunization or for up to 15 mo against a second challenge after an initial challenge of parasites had successfully been cleared (Kaba et al. , 2009 ).
Related Vaccines(s)
P. berghei CS Protein Subunit Vaccine
,
P. berghei DNA vaccine CSP-3p28
,
P. berghei DNA vaccine encoding PbCSP
References
Kaba et al. , 2009: Kaba SA, Brando C, Guo Q, Mittelholzer C, Raman S, Tropel D, Aebi U, Burkhard P, Lanar DE. A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria. Journal of immunology (Baltimore, Md. : 1950) . 2009; 183(11); 7268-7277. [PubMed: 19915055 ].
Gene Information
Gene Name
CS from P. berghei str. ANKA
NCBI Gene ID
3428738
Genbank Accession
LK023119
Chromosome No
4
Locus Tag
PBANKA_040320
Gene Starting Position
126554
Gene Ending Position
127576
DNA Sequence
>NC_036162.1:126554-127576 Plasmodium berghei ANKA genome assembly PBANKA01, chromosome : 4
TTTAATTAAAGAATACTAATACTAATAATATTACAAATCCTAATGAATTGCTTACAATATTAAATATACT
TGAACATTTATCCATTTTACAAATTTCAGTATCAATATCTTCTAAGGTCAAATCTTCTGCTTTCTTATTT
GAACCTTTTCGTTTTCTAACTCTTATACCAGAACCACATGTTACGTTACATTGAGACCATTCCTCTGTGA
TACTATCCCTGATCTGTTTAACAAATTCTAGTATTTTTTCCGCGCTTGGGATATAAGAATCGTCATTATT
ATTATTTTTGTTATTGTTATTACCACCTGGCTGTGGTTGTGGCTGTGGTCGTGGCTGTGGTTGTGGCTGT
GGCTGTGGTTGTGGCTGTGGCTGTGGTTGTGGCTGCGGCCGTGGCTGTGGTTGTGGATTGTTATTTCCTT
GTGGTGGTGCTGGGTCATTTGGGTTTGGTGGTGGTGGGTCATTTGCGTTTGGTGGTGCTGGGTCATTTGG
GTTTGGTGGTGGTGGGTCATTTGCGTTTGGTGGTGCTGGGTCATTTGCGTTTGGTGGTGCTGGGTCATTT
GCGTTTGGTGGTGCTGGGTCATTTGCGTTTGGTGGTGCTGGGTCATTTGCGTTTGGTGGTGGTGGGTCAT
TTGCGTTTGGTGGTGGTGGGTCATTTGGGTTTGGTGGTGGTGGGTCATTTGGGTTTGGTGGTGGTGGGTC
ATTTGGGTTTGGTGGTGGTGGGTCATTTGGGTTTGGTGGTGGTGGTGGTTGTTTCAATTTATTATTACGC
TCTATTTTTTCGTTTTTTTTCTCATTTTTTTTTCCTTCGGGAGCATCGGCAAGTAATCTGTTGACTGTAT
TTCGATTGTATATTTTTCCATTCTTAGAGTTAAGCACGTGATACAATTTATTATCATTTCCTTCATTGTA
ACATAGCTCGTTTAAGTTCCTTTGGGCTTGGATGCTTTTATTTTGTCCATATCCTGGAAGTAGAGAATTA
ACTAATAAAAGTGACGCTACAACTAAAATGGTACACTTCTTCA
Protein Information
NCBI Protein GI
AAA29577.1
Protein Accession
XP_022712148
Protein pI
5.2
Protein Weight
35858.22
Protein Length
340
Protein Sequence
>AAA29577.1 circumsporozoite protein [Plasmodium berghei ANKA]
MKKCTILVVASLLLVNSLLPGYGQNKIIQAQRNLNELCYNEGNDNKLYHVLNSKNGKIYNRNTVNRLLPM
LRRKKNEKKNEKIERNNKLKQPPPPPNPNDPPPPNPNDPPPPNPNDPPPPNPNDPPPPNANDPPPPNAND
PAPPNANDPAPPNANDPAPPNANDPAPPNANDPAPPNANDPAPPNANDPPPPNPNDPAPPQGNNNPQPQP
RPQPQPQPQPQPQPQPQPQPRPQPQPQPGGNNNNKNNNNDDSYIPSAEKILEFVKQIRDSITEEWSQCNV
TCGSGIRVRKRKGSNKKAEDLTLEDIDTEICKMDKCSSIFNIVSNSLGFVILLVLVFFN
Epitope Information
IEDB Linear Epitope
-- Assay Type --
T Cell Epitope
B Cell Epitope
IEDB ID
Epitope
Starting position
Ending position
9598
DPAPPNANDPAPPNAND
140
157
48858
PPPPNPNDPPPPNPND
93
109
43652
NEKIERNNKLKQP
80
93
9723
DPPPPNPNDPPPPNPND
100
117
48690
PNPNDP
96
102
43227
NANDPP
129
135
45420
NPNDPP
97
103
3242
ANDPPP
130
136
48620
PNDPPP
98
104
33003
KQIRDSITEEWS
265
277
41246
MDKCSSIFNIVSNSLGFVIL
313
333
9722
DPPPPNPNDPPPPNPN
100
116
9597
DPAPPNANDPAPPNAN
140
156
43419
NDDSYIPSAEKI
249
261
78635
EKIERNNKLKQPPPPPNPN
81
100
43512
NDPPPPNPNDPAPPQG
187
203
9724
DPPPPNPNDPPPPNPNDPPPPNPN
100
124
180881
PGGNNNNKNNNNDDSYIPSAEKILEFVKQI
238
268
9599
DPAPPNANDPAPPNANDPAPPNAN
140
164
MKKCTILVVASLLLVNSLLPGYGQNKIIQAQRNLNELCYNEGNDNKLYHVLNSKNGKIYNRNTVNRLLPMLRRKKNEKKNEKIERNNKLKQPPPPPNPNDPPPPNPNDPPPPNPNDPPPPNPNDPPPPNANDPPPPNANDPAPPNANDPAPPNANDPAPPNANDPAPPNANDPAPPNANDPAPPNANDPPPPNPNDPAPPQGNNNPQPQPRPQPQPQPQPQPQPQPQPQPRPQPQPQPGGNNNNKNNNNDDSYIPSAEKILEFVKQIRDSITEEWSQCNVTCGSGIRVRKRKGSNKKAEDLTLEDIDTEICKMDKCSSIFNIVSNSLGFVILLVLVFFN